Olfr904, a member of the olfactory receptor family found in Mus musculus (house mouse), is a critical component of the olfactory system. As with other olfactory receptors, Olfr904 belongs to the class of G-protein-coupled receptors (GPCRs), characterized by its seven-transmembrane domain structure. Its primary function lies in its ability to detect and interact with odorant molecules, initiating a complex cascade of intracellular events that eventually lead to the perception of various odors.
Inhibition of Olfr904 can occur through various mechanisms, both direct and indirect. These mechanisms involve targeting various cellular processes and signaling pathways associated with olfactory perception. Direct inhibitors may interfere with the receptor itself, such as by blocking specific receptor sites or disrupting the downstream signaling pathways essential for olfactory signal transduction. Indirect inhibitors, on the other hand, may influence processes related to receptor trafficking, cyclic nucleotide synthesis, or degradation pathways, all of which indirectly impact Olfr904's function in detecting and transmitting olfactory signals. These inhibition mechanisms collectively underscore the intricate and finely tuned regulation of Olfr904 and its pivotal role in the olfactory perception of a wide range of odorous compounds. In conclusion, Olfr904 is a key player in the olfactory system of the house mouse, responsible for detecting and perceiving a diverse array of odors. Its inhibition can occur through diverse mechanisms, reflecting the complexity of olfactory signal processing. Understanding these inhibition mechanisms can provide valuable insights into the fundamental processes of olfaction and the molecular basis of odor detection in mice.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Phosphodiesterase inhibitor that increases cAMP levels. Elevated cAMP disrupts olfactory signal transduction, indirectly suppressing Olfr904 activity. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Calmodulin antagonist that interferes with calcium signaling. Reduced intracellular calcium levels impede Olfr904 activation and downstream signal transduction. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor that disrupts the degradation of Olfr904. Increased stability of Olfr904 protein results in its accumulation and potential suppression of olfactory signaling. | ||||||
Olanzapine | 132539-06-1 | sc-212469 | 100 mg | $133.00 | 6 | |
GPCR antagonist targeting receptors in the olfactory system. Inhibition of these receptors indirectly dampens Olfr904-mediated signal transduction. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
Microtubule destabilizer that affects olfactory cilia structure. Altered cilia structure impairs Olfr904's membrane localization and its interaction with odorant molecules. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Inhibitor of the MAPK pathway, which is involved in olfactory signal transduction. Disruption of this pathway indirectly suppresses Olfr904 function by impeding downstream signaling events. | ||||||
SQ 22536 | 17318-31-9 | sc-201572 sc-201572A | 5 mg 25 mg | $95.00 $363.00 | 13 | |
Adenylyl cyclase inhibitor that reduces cAMP synthesis. Lower cAMP levels lead to decreased Olfr904 activation and downstream signal transduction, indirectly inhibiting olfactory perception. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Inhibitor of olfactory vesicle trafficking pathways. Impaired vesicle transport indirectly hinders Olfr904 membrane expression, affecting its interaction with odorant molecules. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Protein synthesis inhibitor that targets components of the olfactory signaling pathway. Inhibition of protein synthesis indirectly reduces the expression of Olfr904 and its downstream effectors, suppressing olfactory perception. | ||||||
Diltiazem | 42399-41-7 | sc-204726 sc-204726A | 1 g 5 g | $209.00 $464.00 | 4 | |
Calcium channel blocker that interferes with calcium influx. Reduced intracellular calcium levels indirectly suppress Olfr904 activation and its subsequent role in olfactory signal transduction. | ||||||